介质素6:在糖尿病病中是朋友还是敌人?
Renad M Alhamawi1, Walaa Mohammedsaeed1, Maha Aljumaa2
1Department of Clinical Laboratory Sciences, Faculty of Applied Medical Science at Taibah University, AL-Madinah, Saudi Arabia.
Archives of medical science : AMS
|October 13, 2025
概括
在1型糖尿病 (T1D) 患者的血清中较低水平的干白素-6 (IL-6) 与延迟损伤相关. 这表明IL-6是IL-6.
科学领域:
- 内分泌学和糖尿病研究研究
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
背景情况:
- 糖尿病病 (DN) 是1型糖尿病 (T1D) 和2型糖尿病 (T2D) 的主要并发症.
- 血清细胞因子水平,包括IL-6 (IL-6),都与糖尿病的发病和并发症有关.
- 了解IL-6在不同类型糖尿病中在DN中的作用对于有针对性的干预至关重要.
研究的目的:
- 调查血清IL-6水平与糖尿病病 (DN) 之间的关联.
- 为了比较T1D与T2D患者的IL-6水平和DN标志物.
- 探索IL-6作为DN的潜在生物标志物和治疗点.
主要方法:
- 这是一项涉及沙特阿拉伯麦迪纳医院200名患者 (100名T1D,100名T2D) 的横截面研究.
- 评估血清IL-6水平,淋巴膜过率 (GFR) 和白蛋白尿 (UACR).
- 统计分析以确定IL-6,血糖控制 (FBG,HbA1c) 和功能标志物之间的相关性.
主要成果:
- 与T2D患者相比,T1D患者的血清IL-6水平较低.
- 在T1D中,IL-6与空腹血糖和HbA1c有中度的相关性.
- 在T1D中,IL-6与GFR和UACR的相关性很小,表明与功能障碍的联系.
结论:
- 在T1D患者的血清IL-6水平较低可能与损伤的延迟发病有关.
- IL-6的促炎作用表明它对T1D中DN发展的贡献.
- 需要进一步的研究来验证IL-6作为糖尿病病的治疗标.
相关概念视频
01:24Nephrotic Syndrome I : Introduction
499
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
499
01:24Chronic Kidney Disease II: Clinical Manifestations
552
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
552
01:22Acute Kidney Injury VI: Nursing Management
384
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
384
01:24Nephrotic Syndrome III : Nursing Management
279
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
279
01:29Acute Kidney Injury II: Pathophysiology
890
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
890
01:20The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K